Scarica l'app Stockscreener
6.9004
3.84%
-0.2696
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SAGE Giù?
Forum
Previsione
Sage Therapeutics Inc Borsa (SAGE) Ultime notizie
Invesco Ltd. Purchases 4,629 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
What is HC Wainwright’s Forecast for SAGE Q1 Earnings? - Defense World
Sage Therapeutics' Q1 Earnings Miss Mark, Revenue Rise Y/Y - MSN
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2025 Earnings Call Transcript - Insider Monkey
Sage Therapeutics’ Earnings Call Highlights Growth and Uncertainty - TipRanks
Balance Sheet Breakdown: Sage Therapeutics Inc (SAGE)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Sage Therapeutics Inc (SAGE) Q1 2025 Earnings Call Highlights: Strong Demand for ZURZUVAE and ... - Yahoo Finance
SAGE Reports Q1 Revenue Below Estimates, Highlights ZURZUVAE Gro - GuruFocus
Sage Therapeutics Inc (SAGE) Q1 2025 Earnings Call Highlights: S - GuruFocus
Sage Therapeutics Reports Strong Q1 2025 Performance - TipRanks
Sage Therapeutics outlines Q1 2025 growth in ZURZUVAE prescriptions and pipeline progress - MSN
Sage Therapeutics Q1 2025 Earnings: Revenue at $13.8M Misses Est - GuruFocus
Sage Therapeutics, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:SAGE) - Seeking Alpha
Earnings call transcript: Sage Therapeutics misses Q1 2025 EPS forecast By Investing.com - Investing.com Nigeria
Earnings call transcript: Sage Therapeutics misses Q1 2025 EPS forecast - Investing.com
Sage Therapeutics Announces First Quarter 2025 Financial Results - GuruFocus
Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq
Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates - BioSpace
SAGE THERAPEUTICS Earnings Results: $SAGE Reports Quarterly Earnings - Nasdaq
What to Expect from Sage Therapeutics's Earnings - Benzinga
Get in on Sage Therapeutics Inc’s (SAGE) buy-in window today! - Sete News
Sage Therapeutics Inc [SAGE] Insider Activity: An Update for Investors - knoxdaily.com
Sage Therapeutics’ (SAGE) “Hold” Rating Reiterated at Needham & Company LLC - Defense World
Expert Outlook: Sage Therapeutics Through The Eyes Of 4 Analysts - Benzinga
Geode Capital Management LLC Increases Stock Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World
Russell Investments Group Ltd. Lowers Stock Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World
Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm - PR Newswire
Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Sage Therapeutics (SAGE) Projected to Post Quarterly Earnings on Tuesday - Defense World
Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Wedbush Research Analysts Raise Earnings Estimates for SAGE - American Banking and Market News
Lobbying Update: $50,000 of SAGE THERAPEUTICS lobbying was just disclosed - Nasdaq
Q1 EPS Estimates for Sage Therapeutics Increased by Wedbush - Defense World
Q1 Earnings Forecast for SAGE Issued By Wedbush - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Investors to Connect - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect - markets.businessinsider.com
Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025 - BioSpace
Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025 | SAGE Stock News - GuruFocus
Corebridge Financial Inc. Sells 2,050 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Vanguard Group Inc. - Defense World
5.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):